NETRF funds Dr. Iacovos Michael to develop preclinical models and liquid biopsies for NETs. His innovative use of duck eggs efficiently creates preclinical models for personalized therapies. Utilizing microRNAs as circulating biomarkers enables early detection and treatment monitoring.